Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


After License Deal for Letermovir: Head-to-head Phase 2 Trial Initiated by AiCuris to Demonstrate Superiority of its Novel Drug Pritelivir vs. Valacyclovir for Treatment of Genital Herpes

WUPPERTAL, Germany, November 27, 2012 /PRNewswire/ --

Cross-Reference: More Informations are available at: http://www.presseportal.de/pm/106935/

AiCuris announced today that it has started the second clinical efficacy trial with pritelivir (AIC316), its novel anti-herpes simplex virus (HSV) drug in development. After the first trial showed a high efficacy of pritelivir against genital herpes, the present trial AIC316-01-II-02 (NCT01658826, http://www.clinicaltrials.gov) is designed to prove superiority of pritelivir vs. valacyclovir in reducing genital HSV shedding. http://www.aicuris.com/10/News_Publications.htm

"We expect to see superior efficacy of pritelivir in direct comparison with valacyclovir", comments Dr. Alexander Birkmann, project leader for pritelivir. "Reduction of viral shedding is not only extremely relevant for the patients to reduce the risk of transmitting genital herpes to their partner, which is only reduced by 50% with present therapies. It is also a predictor for the potency of pritelivir to treat or even prevent the development of herpes lesions." Furthermore, pritelivir offers very convenient dosing regimens for patients: only one pill for treatment of a herpes episode.

About pritelivir

Pritelivir is a potent inhibitor of HSV replication. It has a new mode of action (inhibition of the viral helicase-primase enzyme complex) and a favorably long plasma half-life. It also stems from a novel chemical class. Pritelivir is active against both labial and genital herpes virus strains and retains activity against viruses which have become resistant to marketed drugs.

In the previous trial pritelivir exhibited a highly significant and dose dependent reduction of viral shedding, of the amount of virus shed, and of clinical lesions under treatment.

Contact:

http://www.Aicuris.com

AiCuris GmbH & Co. KG    

Katja Woestenhemke    
Friedrich-Ebert-Str. 475/Building 302    
42117 Wuppertal
Phone:  +49-202-317-63-1176
Fax:    +49-202-317-63-1177
E-mail: press@aicuris.com


About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
IBM’s Blue Box Cloud, powered by OpenStack, is now available in any of IBM’s globally integrated cloud data centers running SoftLayer infrastructure. Less than 90 days after its acquisition of Blue Box, IBM has integrated its Blue Box Cloud Dedicated private-cloud-as-a-service into it...
Puppet Labs has announced the next major update to its flagship product: Puppet Enterprise 2015.2. This release includes new features providing DevOps teams with clarity, simplicity and additional management capabilities, including an all-new user interface, an interactive graph for vi...
I was experimenting with Java HashSet, which is a pretty expensive collection to create, but it has a benefit of the O(1) performance on the retrieval of elements from this collection. Based on my experiments performance of HashSet is improved over the last year. I’ve written a small ...
When I started exploring virtualization, like many folks, I was in awe of how much efficiency came with moving physical servers into VMs. To this day, the number of success stories about improved usage, reduced overhead costs and increased functionality makes virtualization a solid bus...
XebiaLabs has announced that XL Deploy, its Application Release Automation software, has received certification of its integration with ServiceNow. With XL Deploy from XebiaLabs, ServiceNow users can now easily automate the application deployment process so releases can occur in a re...
All enterprises, be they large or small, national or multinational, commercial or government agency, American or Chinese, Japanese or European, are carrying the dead weight of their history and almost certainly continuing to add unnecessary complexity and excessive cost that will progr...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE